Qiagen N.V. (QGEN) Presents at Bank of America Global Healthcare Conference 2025 TranscriptSeeking Alpha • 09/25/25
QGEN Stock Gains From CE-IVDR Certification for QIAstat-Dx PortfolioZacks Investment Research • 09/15/25
Qiagen N.V. (QGEN) Presents At Baird Global Healthcare Conference 2025 Prepared Remarks TranscriptSeeking Alpha • 09/10/25
Qiagen N.V. (QGEN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/09/25
QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx RiseZacks Investment Research • 09/03/25
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic TestingBusiness Wire • 09/02/25
QIAGEN N.V. Announces Conversion Price of New Net Share Settled Convertible BondsBusiness Wire • 08/28/25
QIAGEN N.V. Announces Successful Placement of New Net Share Settled Convertible BondsBusiness Wire • 08/28/25
Why Qiagen (QGEN) International Revenue Trends Deserve Your AttentionZacks Investment Research • 08/11/25
QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitabilityBusiness Wire • 08/05/25
QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory BoardBusiness Wire • 06/26/25